CAR_TRANSPLANTS_LIMITED - Accounts


Company Registration No. 02030091 (England and Wales)
CAR TRANSPLANTS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 OCTOBER 2016
CAR TRANSPLANTS LIMITED
COMPANY INFORMATION
Directors
J A Schofield
P A Schofield
M R M Schofield
Secretary
J A Schofield
Company number
02030091
Registered office
Wharton Industrial Estate
Wharton Road
Winsford
Cheshire
CW7 3BQ
Auditor
Afford Bond Holdings Limited
31 Wellington Road
Nantwich
Cheshire
CW5 7ED
CAR TRANSPLANTS LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 5
Statement of income and retained earnings
6
Balance sheet
7
Statement of cash flows
8
Notes to the financial statements
9 - 22
CAR TRANSPLANTS LIMITED
STRATEGIC REPORT
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 1 -

The directors present the strategic report for the period ended 31 October 2016.

Fair review of the business

 

The directors consider that the results and financial position at the period ended 31 October 2016 are satisfactory based on the current economic conditions.

 

Turnover has increased to £47.2m for a 12 month period (2015 - £48.8m for an 18 month period).

 

Gross profit margin has increased to 10.54% (2015 - 8.17%).

 

Overall the company is reporting a pre-tax profit of £2.4m (2015 - £0.9m).

Principal risks and uncertainties

The principle risks and uncertainties facing the business are the strength of the second hand car market and the valuation percentages offered by insurers. The directors seek to mitigate these risks by only entering into contracts with insurers which are clearly profitable overall.

Key performance indicators

The key performance indicators used by the directors are turnover, gross margin and profit before tax. These are as reported above.

On behalf of the board

J A Schofield
Director
10 May 2017
CAR TRANSPLANTS LIMITED
DIRECTORS' REPORT
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 2 -

The directors present their annual report and financial statements for the period ended 31 October 2016.

Principal activities
The principal activity of the company continued to be that of motor salvage dealers.
Directors

The directors who held office during the period and up to the date of signature of the financial statements were as follows:

J A Schofield
P A Schofield
M R M Schofield
Results and dividends

The results for the period are set out on page 6.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Auditor

In accordance with the company's articles, a resolution proposing that Afford Bond Holdings Limited be reappointed as auditor of the company will be put at a General Meeting.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations. Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to: •    select suitable accounting policies and then apply them consistently; •    make judgements and accounting estimates that are reasonable and prudent; •    prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

  • select suitable accounting policies and then apply them consistently;

  • make judgements and accounting estimates that are reasonable and prudent;

  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

CAR TRANSPLANTS LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 3 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

On behalf of the board
J A Schofield
Director
10 May 2017
CAR TRANSPLANTS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CAR TRANSPLANTS LIMITED
- 4 -

We have audited the financial statements of Car Transplants Limited for the period ended 31 October 2016 set out on pages 6 to 22. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".

 

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Respective responsibilities of directors and auditor

As explained more fully in the Directors' Responsibilities Statement set out on pages 2 - 3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors.

Scope of the audit of the financial statements

An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the company's circumstances and have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by the directors; and the overall presentation of the financial statements. In addition, we read all the financial and non-financial information in the annual report to identify material inconsistencies with the audited financial statements and to identify any information that is apparently materially incorrect based on, or materially inconsistent with, the knowledge acquired by us in the course of performing the audit. If we become aware of any apparent material misstatements or inconsistencies we consider the implications for our report.

Opinion on financial statements

In our opinion the financial statements: •    give a true and fair view of the state of the company's affairs as at 31 October 2016 and of its profit for the period then ended; •    have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and •    have been prepared in accordance with the requirements of the Companies Act 2006.

  • give a true and fair view of the state of the company's affairs as at 31 October 2016 and of its profit for the period then ended;

  • have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  • have been prepared in accordance with the requirements of the Companies Act 2006.

Opinion on other matter prescribed by the Companies Act 2006

In our opinion the information given in the Strategic Report and the Directors' Report for the financial period for which the financial statements are prepared is consistent with the financial statements.true

CAR TRANSPLANTS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CAR TRANSPLANTS LIMITED
- 5 -
Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: •    adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or •    the financial statements are not in agreement with the accounting records and returns; or •    certain disclosures of directors' remuneration specified by law are not made; or •    we have not received all the information and explanations we require for our audit.

 

  • adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  • the financial statements are not in agreement with the accounting records and returns; or

  • certain disclosures of directors' remuneration specified by law are not made; or

  • we have not received all the information and explanations we require for our audit.

Paul Edwards FCCA CTA (Senior Statutory Auditor)
for and on behalf of Afford Bond Holdings Limited
10 May 2017
Chartered Accountants
Statutory Auditor
31 Wellington Road
Nantwich
Cheshire
CW5 7ED
CAR TRANSPLANTS LIMITED
STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 6 -
12 month period
18 month period
ended
ended
31 October
31 October
2016
2015
Notes
£
£
Turnover
2
47,188,862
48,770,668
Cost of sales
(42,216,924)
(44,787,182)
Gross profit
4,971,938
3,983,486
Administrative expenses
(2,539,394)
(3,048,790)
Operating profit
3
2,432,544
934,696
Interest receivable and similar income
6
-
64,384
Interest payable and similar charges
7
(51,692)
(100,044)
Profit before taxation
2,380,852
899,036
Taxation
8
(449,800)
(221,162)
Profit for the financial period
1,931,052
677,874
Retained earnings at 1 November 2015
2,448,383
1,910,509
Dividends
9
-
(140,000)
Retained earnings at 31 October 2016
4,379,435
2,448,383

The profit and loss account has been prepared on the basis that all operations are continuing operations.

CAR TRANSPLANTS LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2016
31 October 2016
- 7 -
2016
2015
Notes
£
£
£
£
Fixed assets
Goodwill
10
-
59,583
Tangible assets
11
1,764,011
1,581,957
1,764,011
1,641,540
Current assets
Stocks
13
2,241,010
1,511,825
Debtors
14
5,579,239
4,923,462
Cash at bank and in hand
1,562
400
7,821,811
6,435,687
Creditors: amounts falling due within one year
15
(4,277,960)
(5,007,607)
Net current assets
3,543,851
1,428,080
Total assets less current liabilities
5,307,862
3,069,620
Creditors: amounts falling due after more than one year
16
(621,750)
(265,330)
Provisions for liabilities
19
(156,578)
(205,808)
Net assets
4,529,534
2,598,482
Capital and reserves
Called up share capital
22
150,099
150,099
Profit and loss reserves
4,379,435
2,448,383
Total equity
4,529,534
2,598,482
The financial statements were approved by the board of directors and authorised for issue on 10 May 2017 and are signed on its behalf by:
J A Schofield
Director
Company Registration No. 02030091
CAR TRANSPLANTS LIMITED
STATEMENT OF CASH FLOWS
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 8 -
2016
2015
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
27
2,283,382
517,921
Interest paid
(51,692)
(100,044)
Income taxes paid
(74,106)
-
Net cash inflow from operating activities
2,157,584
417,877
Investing activities
Purchase of tangible fixed assets
(87,473)
(1,086,375)
Proceeds on disposal of tangible fixed assets
13,391
-
Proceeds from other investments and loans
(15,000)
-
Interest received
-
64,384
Net cash used in investing activities
(89,082)
(1,021,991)
Financing activities
Proceeds of new bank loans
1,212,000
-
Repayment of bank loans
(588,856)
(25,554)
Payment of finance leases obligations
(426,247)
(191,070)
Dividends paid
-
(140,000)
Net cash generated from/(used in) financing activities
196,897
(356,624)
Net increase/(decrease) in cash and cash equivalents
2,265,399
(960,738)
Cash and cash equivalents at beginning of period
(2,304,616)
(1,343,878)
Cash and cash equivalents at end of period
(39,217)
(2,304,616)
Relating to:
Cash at bank and in hand
1,562
400
Bank overdrafts included in creditors payable within one year
(40,779)
(2,305,016)
CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 9 -
1
Accounting policies
Company information

Car Transplants Limited is a private company limited by shares incorporated in England and Wales. The registered office is Wharton Industrial Estate, Wharton Road, Winsford, Cheshire, CW7 3BQ.

1.1
Accounting convention

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

These financial statements for the period ended 31 October 2016 are the first financial statements of Car Transplants Limited prepared in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 1 May 2014. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business , and is shown net of VAT and other sales related taxes . The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates. When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income., and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years. For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit. amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
1
Accounting policies
(Continued)
- 10 -
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
25% reducing balance
Fixtures, fittings & equipment
25% reducing balance
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. Stocks held for distribution at no or nominal consideration are measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
1
Accounting policies
(Continued)
- 11 -
1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss , are assessed for indicators of impairment at each reporting end date. Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
1
Accounting policies
(Continued)
- 12 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value though profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
1
Accounting policies
(Continued)
- 13 -
Deferred tax
Deferred tax is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes. The deferred tax balance has not been discounted.
1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets. The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received. Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases. Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to the profit and loss account so as to produce a constant periodic rate of interest on the remaining balance of the liability.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to the profit and loss account so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

2
Turnover and other revenue

An analysis of the company's turnover is as follows:

2016
2015
£
£
Turnover
Sale of vehicles
47,188,862
48,770,668
Other significant revenue
Interest income
-
64,384
CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
2
Turnover and other revenue
(Continued)
- 14 -
Turnover analysed by geographical market
2016
2015
£
£
UK
46,461,262
48,477,457
Other EU Member States
628,690
277,731
Rest of the World
98,910
15,480
47,188,862
48,770,668
3
Operating profit
2016
2015
Operating profit for the period is stated after charging/(crediting):
£
£
Fees payable to the company's auditor for the audit of the company's financial statements
3,500
14,850
Depreciation of owned tangible fixed assets
285,795
466,150
Depreciation of tangible fixed assets held under finance leases
234,361
53,143
Loss on disposal of tangible fixed assets
612
-
Amortisation of intangible assets
59,583
7,500
Cost of stocks recognised as an expense
40,491,178
42,361,129
Operating lease charges
472,100
569,150
4
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2016
2015
Number
Number
Administration
61
59

Their aggregate remuneration comprised:

2016
2015
£
£
Wages and salaries
1,297,780
1,733,598
Social security costs
115,012
148,171
Pension costs
7,750
-
1,420,542
1,881,769
CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 15 -
5
Directors' remuneration
2016
2015
£
£
Remuneration for qualifying services
6,987
7,569
6
Interest receivable and similar income
2016
2015
£
£
Interest income
Other interest income
-
64,384
7
Interest payable and similar charges
2016
2015
£
£
Interest on financial liabilities measured at amortised cost:
Interest on bank overdrafts and loans
26,539
89,665
Interest on finance leases and hire purchase contracts
25,153
10,379
51,692
100,044
8
Taxation
2016
2015
£
£
Current tax
UK corporation tax on profits for the current period
499,030
74,106
Adjustments in respect of prior periods
-
(17)
Total current tax
499,030
74,089
Deferred tax
Origination and reversal of timing differences
(49,230)
147,073
Total tax charge
449,800
221,162
CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
8
Taxation
(Continued)
- 16 -

The actual charge for the period can be reconciled to the expected charge for the period based on the profit or loss and the standard rate of tax as follows:

2016
2015
£
£
Profit before taxation
2,380,852
899,036
Expected tax charge based on the standard rate of corporation tax in the UK of 20.00% (2015: 20.00%)
476,170
179,807
Amortisation on assets not qualifying for tax allowances
11,917
-
Deferred tax adjustments in respect of prior years
(38,287)
41,355
Taxation for the period
449,800
221,162
9
Dividends
2016
2015
£
£
Interim paid
-
140,000
10
Intangible fixed assets
Goodwill
£
Cost
At 1 November 2015 and 31 October 2016
100,000
Amortisation and impairment
At 1 November 2015
40,417
Amortisation charged for the period
59,583
At 31 October 2016
100,000
Carrying amount
At 31 October 2016
-
At 31 October 2015
59,583
CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 17 -
11
Tangible fixed assets
Plant and machinery
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
£
Cost
At 1 November 2015
2,041,642
239,210
880,388
3,161,240
Additions
585,250
24,343
106,620
716,213
Disposals
(23,500)
-
-
(23,500)
At 31 October 2016
2,603,392
263,553
987,008
3,853,953
Depreciation and impairment
At 1 November 2015
714,121
133,695
731,467
1,579,283
Depreciation charged in the period
429,589
28,903
61,664
520,156
Eliminated in respect of disposals
(9,497)
-
-
(9,497)
At 31 October 2016
1,134,213
162,598
793,131
2,089,942
Carrying amount
At 31 October 2016
1,469,179
100,955
193,877
1,764,011
At 31 October 2015
1,327,521
105,515
148,921
1,581,957

The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.

2016
2015
£
£
Plant and machinery
818,875
582,156
Motor vehicles
82,186
-
901,061
582,156
Depreciation charge for the period in respect of leased assets
234,361
53,143
12
Financial instruments
2016
2015
£
£
Carrying amount of financial assets
Debt instruments measured at amortised cost
5,329,975
4,663,554
Carrying amount of financial liabilities
Measured at amortised cost
4,129,933
5,011,203
CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 18 -
13
Stocks
2016
2015
£
£
Finished goods and goods for resale
2,241,010
1,511,825
14
Debtors
2016
2015
Amounts falling due within one year:
£
£
Trade debtors
275,578
687,013
Amount due from parent undertaking
-
3,976,541
Amounts due from fellow group undertakings
5,039,397
-
Other debtors
15,000
-
Prepayments and accrued income
249,264
259,908
5,579,239
4,923,462
15
Creditors: amounts falling due within one year
2016
2015
Notes
£
£
Bank loans and overdrafts
17
567,409
2,447,102
Obligations under finance leases
18
285,106
200,433
Trade creditors
2,060,643
1,833,894
Corporation tax
499,030
74,106
Other taxation and social security
270,747
187,628
Other creditors
421,626
43,800
Accruals and deferred income
173,399
220,644
4,277,960
5,007,607
16
Creditors: amounts falling due after more than one year
2016
2015
Notes
£
£
Bank loans and overdrafts
17
273,960
35,360
Obligations under finance leases
18
347,790
229,970
621,750
265,330
CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 19 -
17
Loans and overdrafts
2016
2015
£
£
Bank loans
800,590
177,446
Bank overdrafts
40,779
2,305,016
841,369
2,482,462
Payable within one year
567,409
2,447,102
Payable after one year
273,960
35,360

The long-term loans are secured by a cross guarantee and debenture between Car Transplants (Holdings) Limited, Car Transplants (Hurleston) Limited and Car Transplants Recycling Limited.

The long term bank loans are repayable in monthly instalments.

18
Finance lease obligations
2016
2015
Future minimum lease payments due under finance leases:
£
£
Within one year
307,916
219,167
In two to five years
379,111
240,369
In over five years
9,519
-
696,546
459,536
Less: future finance charges
(63,650)
(29,133)
632,896
430,403

Finance lease payments represent rentals payable by the company for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.

19
Provisions for liabilities
2016
2015
Notes
£
£
Deferred tax liabilities
20
156,578
205,808
156,578
205,808
CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 20 -
20
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2016
2015
Balances:
£
£
Accelerated capital allowances
156,578
205,808
2016
Movements in the period:
£
Liability at 1 November 2015
205,808
Credit to profit or loss
(49,230)
Liability at 31 October 2016
156,578
21
Retirement benefit schemes
2016
2015
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
7,750
-

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

22
Share capital
2016
2015
£
£
Ordinary share capital
Issued and fully paid
150,099 Ordinary shares of £1 each
150,099
150,099
CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 21 -
23
Operating lease commitments
Lessee

Operating lease payments represent rentals payable by the company for certain of its properties.

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2016
2015
£
£
Within one year
453,100
453,100
24
Related party transactions
Transactions with related parties

During the period the company entered into the following transactions with related parties:

Sale of goods
Purchase of goods
2016
2015
2016
2015
£
£
£
£
Entities with control, joint control or significant influence over the company
256,525
3,739,611
-
129,485
Rent payable
2016
2015
£
£
Entities with control, joint control or significant influence over the company
453,100
569,150

The following amounts were outstanding at the reporting end date:

2016
2015
Amounts owed to related parties
£
£
Entities with control, joint control or significant influence over the company
300,175
218,862
Key management personnel
111,452
-
411,627
218,862

No guarantees have been given or received.

CAR TRANSPLANTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 OCTOBER 2016
- 22 -
25
Directors' transactions

Interest free loans have been granted by the company to its directors as follows:

Description
% Rate
Opening balance
Amounts advanced
Closing balance
£
£
£
Loans to directors
-
-
15,000
15,000
-
15,000
15,000
26
Controlling party

The parent company of Car Transplants Limited is Car Transplants (Holdings) Limited, a company incorporated in England & Wales.

 

Car Transplants (Holdings) Limited is the head of the group into which Car Transplants Limited is consolidated.

27
Cash generated from operations
2016
2015
£
£
Profit for the period after tax
1,931,052
677,874
Adjustments for:
Taxation charged
449,800
221,162
Finance costs
51,692
100,044
Investment income
-
(64,384)
Loss on disposal of tangible fixed assets
612
-
Amortisation and impairment of intangible assets
59,583
7,500
Depreciation and impairment of tangible fixed assets
520,156
519,293
Movements in working capital:
(Increase) in stocks
(729,185)
(461,578)
(Increase) in debtors
(640,777)
(2,030,275)
Increase in creditors
640,449
1,548,285
Cash generated from operations
2,283,382
517,921
2016-10-312015-11-01falseCCH SoftwareCCH Accounts Production 2017.101020300912015-11-012016-10-3102030091bus:CompanySecretaryDirector12015-11-012016-10-3102030091bus:Director12015-11-012016-10-3102030091bus:Director22015-11-012016-10-3102030091bus:CompanySecretary12015-11-012016-10-3102030091bus:RegisteredOffice2015-11-012016-10-31020300912016-10-31020300912014-05-012015-10-3102030091core:RetainedEarningsAccumulatedLosses2014-05-012015-10-3102030091core:Goodwill2015-10-31020300912015-10-3102030091core:PlantMachinery2016-10-3102030091core:FurnitureFittings2016-10-3102030091core:MotorVehicles2016-10-3102030091core:PlantMachinery2015-10-3102030091core:FurnitureFittings2015-10-3102030091core:MotorVehicles2015-10-3102030091core:CurrentFinancialInstruments2016-10-3102030091core:CurrentFinancialInstruments2015-10-3102030091core:Non-currentFinancialInstruments2016-10-3102030091core:Non-currentFinancialInstruments2015-10-3102030091core:ShareCapital2016-10-3102030091core:ShareCapital2015-10-3102030091core:RetainedEarningsAccumulatedLosses2016-10-3102030091core:RetainedEarningsAccumulatedLosses2015-10-3102030091core:HedgingReservecore:RestatedAmount2014-04-3002030091core:CapitalRedemptionReservecore:RestatedAmount2014-04-300203009112015-11-012016-10-310203009122015-11-012016-10-310203009112014-05-012015-10-3102030091core:Goodwill2015-11-012016-10-3102030091core:PlantMachinery2015-11-012016-10-3102030091core:FurnitureFittings2015-11-012016-10-3102030091core:MotorVehicles2015-11-012016-10-3102030091core:OwnedAssets2015-11-012016-10-3102030091core:OwnedAssets2014-05-012015-10-3102030091core:LeasedAssets2015-11-012016-10-3102030091core:LeasedAssets2014-05-012015-10-3102030091core:UKTax2015-11-012016-10-3102030091core:UKTax2014-05-012015-10-3102030091core:Goodwill2015-10-3102030091core:Goodwill2016-10-3102030091core:PlantMachinery2015-10-3102030091core:FurnitureFittings2015-10-3102030091core:MotorVehicles2015-10-31020300912015-10-3102030091core:WithinOneYear2016-10-3102030091core:WithinOneYear2015-10-3102030091core:BetweenTwoFiveYears2016-10-3102030091core:BetweenTwoFiveYears2015-10-3102030091core:MoreThanFiveYears2016-10-3102030091bus:PrivateLimitedCompanyLtd2015-11-012016-10-3102030091bus:FRS1022015-11-012016-10-3102030091bus:Audited2015-11-012016-10-3102030091bus:FullAccounts2015-11-012016-10-31xbrli:purexbrli:sharesiso4217:GBP